# COSCIENS Biopharma Posts $2.5 Million in Q3 Revenue and $3.45 GAAP Loss Per Share

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/57140
Published: 2026-11-14T02:38:06.000Z
Updated: 2026-11-14T02:38:06.000Z
Section: Business

> Revenue rose 66.7% from a year earlier.

COSCIENS Biopharma Inc. posted third-quarter revenue of $2.5 million, up 66.7% from the same period a year earlier, while recording a GAAP loss of $3.45 per share.